- Details
- Description
Packaging Size:
60 capsules per HDPE container according to the manufacturer's product information.
Strength:
100 mg
Composition:
Acalabrutinib 100 mg per capsule
Treatment:
Targeted therapy for certain B-cell cancers, including mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), and small lymphocytic lymphoma (SLL).
Form:
Capsule
Brand:
Acaluxen 100 mg
Quantity Unit:
Capsule
Manufacturer:
Everest Pharmaceuticals Ltd., Bangladesh
Acaluxen 100 mg Capsule (Acalabrutinib 100 mg) is an oral targeted anticancer medicine belonging to the Bruton’s tyrosine kinase (BTK) inhibitor class. It works by blocking BTK signaling, which helps reduce the growth and survival of abnormal B cells. Acaluxen is used in adults for certain B-cell blood cancers, including mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), and small lymphocytic lymphoma (SLL), depending on the specific indication and treatment regimen. It is taken orally and should be used under the supervision of an oncologist or qualified healthcare professional.
